An interventional study of Caloric restriction and Light exposure in Alertness, Fatigue, Mood, and Performance and Calorie Restriction and Light Intervention, sponsored by National Aeronautics and Space Administration (NASA). Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by National Aeronautics and Space Administration (NASA) · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 704 studies in Fatigue with a site in United States — 91 open to participants now, 113 under way, 10 of them phase 3. Fatigue · United States.
Among the 704 studies in Fatigue with a site in United States, this one is the 139th largest by planned enrollment of the 610 interventional ones that give a count, is one of 39 that started in 2026, is one of 414 with no phase, reaches primary completion later than 100 of the 112 other live ones, and was the 689th registered.
2,232 studies on the registry are indexed under Fatigue; 427 are open to participants now.
Browse Fatigue studies →91 of the 704 studies in Fatigue with a site in United States are open now. Recruiting first, the newest first:
University of Iowa · Sites in United States
Ages 45–70
University of Alabama at Birmingham · Sites in United States
Ages 18–50 · Women only
Bioligent · Sites in United States
Ages 18–60 · Healthy volunteers
Qualia Life Sciences · Sites in United States
Ages 25–75 · Healthy volunteers
University of Florida · Sites in United States
Ages 6+ · Men only
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 239 Fatigue studies recruiting now, 111 (46%) set no upper age limit and 98 (41%) stop at 75 or younger; 23 take children under 18; 73 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
704 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 44 · Phase 2 105 · Phase 3 58 · Phase 4 26
First in 1998; this study’s year is marked. 39 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 118 is above the median of 54 across 1,760 interventional studies indexed under Fatigue.
Median enrollment 47 across the 610 interventional studies, 82 across the 86 observational. Of the 538 that completed or were terminated, 174 (32%) have results posted.
This tab as a report to print or save as PDF → With an account.
84 of 704 have an industry lead sponsor. The 10 most frequent:
National Aeronautics and Space Administration (NASA) is the lead sponsor of 14 studies on the registry; 5 are open to participants now.
National Aeronautics and Space Administration (NASA) has 2 studies filed under Fatigue — fewer than ten, so there is no comparison to draw.
45 of the studies in Fatigue with a site in United States that are under way reach primary completion within a year, 5 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05474846Phase 3M.D. Anderson Cancer CenterCombination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer | 2027-02-28 |
| NCT07455383Phase 3Alkermes, Inc.A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 | 2027-05 |
| NCT06085716Phase 3M.D. Anderson Cancer CenterCombination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers | 2027-08-31 |
| NCT07675135Phase 3Harmony Biosciences Management, Inc.A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy | 2027-10 |
| NCT07500090Phase 3Harmony Biosciences Management, Inc.A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH) | 2027-10 |
Add all 45 to your calendar (.ics) → With an account.
Among the 704 studies in Fatigue with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of the present study is to test novel countermeasures to reduce fatigue among airline pilots during long-haul flight operations. The investigators will collect objective and subjective sleep, sleepiness, workload, and performance data from active-duty line pilots flying long-haul flight operations (>8 hours). Data will be collected during days off prior to the trip start, during flights and layover, and during days off following the trip end.
This study will evaluate whether a calorie restriction and lighting countermeasure are capable of improving performance and reducing fatigue and sleepiness among commercial airline pilots during trips that involve long-haul (LH) overnight operations. All participants will collect data for two LH trips that involve overnight flying, and for three days before and after each trip. All participants will collect baseline data for one trip with no intervention. Upon completion of the baseline trip, participants will be randomized to receive the intervention or control for a future similar trip. The intervention will involve asking pilots to reduce their calorie intake during the biological night to \< 10% of their daily need and to wear blue-enriched light emitting glasses for 20 minutes following their inflight rest break before they return to the flight deck. The control condition will involve reminding pilots about standard fatigue risk management practices that are recommended by their company.
Specific Aims: The aim of this study is to determine whether a calorie restriction and lighting intervention will improve alertness and performance during LH flight operations compared to standard fatigue risk management practices among pilots flying LH overnight operations during outbound and return flights.
Hypotheses:
We hypothesize that:
Primary Outcome Measures:
We will measure self-reported sleepiness using the Karolinska Sleepiness Scale (KSS), which is a 9-item Likert scale that is used to assess sleepiness. We will measure self-reported fatigue using the Samn-Perelli scale (SP), which is a 7-item Likert scale that is used to assess fatigue. We will measure mood using a series of visual analog scales (VAS). We will measure objective cognitive performance using the five-minute psychomotor vigilance task (PVT), a simple reaction time task with outcome measures including mean reaction time, response speed (1/reaction time) and number of lapses (reaction time >500ms). These outcomes will be assessed throughout the study, with primary comparisons between conditions evaluated \~20 minutes after waking from inflight rest and at the top of TOD of each flight.
We will also collect a number of secondary outcomes to use as co-variates in analysis and to conduct exploratory analyses. These include measures taken three days before and after each trip, during layover, and also at the top of climb (TOC) for each flight. The specific measures that we will collect are outlined below and include objective and subjective sleep outcomes, exercise information, food intake timing and composition, hunger, workload, and perceived performance. We will also collect a number of baseline questionnaires to document demographics and typical sleep and eating habits.
Participants will begin data collection 3 days prior to their trip departure. At the start of data collection (for each trip), participants will begin wearing the activity monitor and continuous glucose monitor and continue to wear them for the duration of the study period which will conclude 3 days following their return from their trip. They will make entries in the apps, reporting on their sleep periods, food intake, and exercise each day. Participants will collect additional data on duty characteristics (hassle factors like delays, air traffic control issues, countermeasures employed, hotel issues, etc.) during the trip. Participants will be asked to complete a follow-up survey/debrief about their experience 1-3 months following their participation.
Measures Morning Sleep Log. At the beginning of each day, participants will complete a sleep log within the NASA PVT+ App. Each entry will include: wake-up time, a rating of sleep quality (5-point scale from Extremely Good to Extremely Poor), the Samn-Perelli (SP) and Karolinska Sleepiness Scale (KSS), the location of their sleep, the timing and duration of any awakenings during the sleep period, and any additional information (i.e., notes). Pre- and post-flight naps will be logged separately.
Evening Sleep Log. At the end of each day (right before sleep), participants will use the NASA PVT+ app to log the time they are going to sleep and any naps taken since the last sleep entry (including timing and duration). Participants will also complete the SP and KSS and have an opportunity to provide any additional comments about the day if necessary.
Flight Duty Period Data Collection. On flight duty days, participants will have additional entries and tasks to complete within the NASA PVT+ app (i.e., pre-duty, during flight, post-flight, and post-duty).
Food and fluid intake. Participants will document their food and fluid intake throughout the entire data collection period using the LoseIt! application. The LoseIt! app will be set up by the study team so that it does not include any personally identifiable information (i.e., a code will be used instead of the participant's name). Participants will be instructed to document their food and fluid intake as they consume it. The data will be checked by study staff each day to ensure the participant completed data input.
Morningness/Eveningness Questionnaire (MEQ). The MEQ is a widely used self-assessment questionnaire (19 items) designed to determine a person's chronotype, that is, whether they experience peak alertness in the morning, evening or in between. The MEQ will be administered at the beginning of the study as part of the baseline demographic series of questionnaires.
Epworth Sleepiness Scale (ESS). The ESS routinely used self-administered questionnaire (8 items) that can be used to assess daytime sleepiness. The ESS will be administered at the beginning of the study as part of the baseline demographic series of questionnaires.
Insomnia Severity Index (ISI). The ISI is a 7-item questionnaire used to assess the severity of daytime and nighttime components of insomnia. The scale uses a 5-point Likert scale to measure the different components, including: severity sleep onset, sleep maintenance, early morning awakening problems, sleep dissatisfaction, interference of sleep difficulties with daytime function, noticeability of sleep problems by others, and distress caused by the sleep difficulties. Total score can range from 0-28 with higher scores indicating more severe insomnia. The ISI will be administered at the beginning of the study as part of the baseline demographic series of questionnaires.
Pittsburgh Sleep Quality Index (PSQI). The PSQI is a 19-item questionnaire that quantifies sleep quality, latency, and duration, and daytime dysfunction into a single score that distinguishes good from poor sleepers. The PSQI will be administered at the beginning of the study as part of the baseline demographic series of questionnaires.
The Big Five Personality Inventory - 2 (BFI-2). The BFI-2 is an updated version of the BFI-1 with further breakdowns (i.e., "facets") of each of the 5 dimensions/trait: Extraversion (with facets of Sociability, Assertiveness, and Energy Level), Agreeableness (Compassion, Respectfulness, and Trust), Conscientiousness (Organization, Productiveness, and Responsibility), Negative Emotionality (Anxiety, Depression, and Emotional Volatility), and Open-Mindedness (Intellectual Curiosity, Aesthetic Sensitivity, and Creative Imagination). The original BFI-2 is 60 items. The BFI-2 will be administered at the beginning of the study as part of the baseline demographic series of questionnaires.
The Chrononutrition Questionnaire (CP-Q). The CP-Q is an 18-item questionnaire that assess general patterns of chrononutrition preferences and chrononutrition behaviors, on typical work/school days and free days. The CP-Q will be administered at the beginning of the study as part of the baseline demographic series of questionnaires.
NASA-TLX. The NASA Task Load Index (TLX) is a subjective, multidimensional tool that rates workload relative to a task. The TLX is taken at the start of the study to make a series of pairwise comparisons and then again for rating each flight duty period.
Hassle Factors. Factors that may affect workload during flight operations (e.g., weather, ATC, cabin activity, procedures \& documentation) will be reported for the flight duty period. Hassle Factors are collected in post-flight using the NASA PVT+ App.
Samn-Perelli Scale (SP). The Samn-Perelli Scale is a commonly used 7-point scale for self-rating levels of fatigue at a given time. The scale: 1= fully alert - wide awake, 2= very lively, 3= okay - somewhat fresh, 4= a little tired, 5= moderately tired, 6= extremely tired, 7= completely exhausted.
Karolinska Sleepiness Scale (KSS). The KSS is a widely used 9-point scale for self-rating levels of sleepiness at a given time. The scale: 1 = extremely alert, 2= very alert, 3 = alert, 4= rather alert, 5 = neither alert nor sleepy, 6= some signs of sleepiness, 7 = sleepy - but no difficulty remaining awake, 8= sleepy - some effort to keep awake, and 9 = extremely sleepy - fighting sleep.
Sleep Quality rating. All sleep periods (including naps) will be rated for quality. The scale: 1 = extremely good, 2= good, 3 = average, 4= poor, 5 = extremely poor.
Visual analog scales (VAS) of mood. A series of 100-point bi-anchored mood scales including the following pairs: alert-sleepy, cheerful-miserable, calm-tense, depressed-elated, stressed-relaxed, peaceful-hostile, greedy-generous, aggressive-easygoing, lethargic-energetic. Participants mark on the horizontal line to indicate how they are currently feeling. The VAS will be administered in conjunction with the PVT, KSS, and SP.
Self-Reported Performance Rating. Participants will be asked to rate how well they thought they performed after each test bout on a 7-point scale ranging from "extremely good" to "extremely poor". The scale will be administered before and after each PVT.
Psychomotor vigilance task (PVT). The PVT is a widely used sustained-attention, reaction-time task that measures the speed with which subjects respond to a visual stimulus. The PVT is a simple task where the subject taps the screen as soon as a visual stimulus appears. The stimulus appears randomly every few seconds during the 5-minute task.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The intervention will involve asking pilots to reduce their calorie intake during the biological night to \< 10% of their daily need and to wear blue-enriched light emitting glasses for 20 minutes following their inflight rest break before they return to the flight deck during both outbound and return flights
Behavioral: Caloric restriction · Device: Light exposure
The control condition will involve reminding pilots about standard fatigue risk management practices that are recommended by their company.
To reduce calorie intake during the biological night to \< 10% of calculated daily need.
To wear blue-enriched light emitting glasses for 20 minutes following an inflight rest break before returning to the flight deck during both outbound and return flights.
Vigilant Attention
Measured using the 5-minute Psychomotor Vigilance Task (PVT); a simple reaction time test with measures that include mean reaction time, response speed (1/RT), and number of lapses (RT \> 500ms).
Time frame: minimum of 18 days, morning, afternoon, evening and top of descent of all flights
Subjective Sleepiness
Measured using the Karolinska Sleepiness Scale (KSS); a 9-point Likert scale with higher scores indicating higher levels of sleepiness.
Time frame: Minimum of 18 days, morning, afternoon, evening and top of descent of all flights
Subjective Fatigue
Measured using the Samn-Perelli fatigue scale; a 7-point Likert scale with higher scores indicating higher levels of fatigue
Time frame: minimum of 18 days, morning, afternoon, evening and top of descent of all flights
Objective Sleep
Measured using an accelerometer (wristwatch-like device) and light sensor to determine sleep and wake patterns and various other objective sleep metrics (e.g., sleep onset, wake after sleep onset, total sleep time).
Time frame: 24 hours a day for a minimum of 18 days
Plan to share: Undecided
Start is estimated for Dec 2026; primary completion for Jul 2029, 31 months later.
Of 936 non-industry interventional studies with no phase under Fatigue, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 31 months is above that.
Counting every sponsor, half of 989 studies reached it within 12 months; a quarter within 5 and three quarters within 27.
Start moved once since we started tracking on Sep 25, 2026: Sep 2026 → Dec 2026, on Nov 16, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Aeronautics and Space Administration (NASA)